Holen Sie sich die Stockscreener-App
24.49
0.79%
-0.1972
Schlusskurs vom Vortag:
$24.69
Offen:
$24.46
24-Stunden-Volumen:
364.52K
Relative Volume:
0.14
Marktkapitalisierung:
$3.08B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
2,449.28
EPS:
0.01
Netto-Cashflow:
$-383.00M
1W Leistung:
+3.01%
1M Leistung:
+6.64%
6M Leistung:
+171.86%
1J Leistung:
+185.16%
1-Tages-Spanne:
$23.99
$24.97
1-Wochen-Bereich:
$23.55
$25.49
52-Wochen-Spanne:
$7.62
$25.49
Indivior Plc Stock (INDV) Company Profile
Firmenname
Indivior Plc
Sektor
Telefon
804-379-1090
Adresse
234 BATH ROAD, SLOUGH, BERKSHIRE
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
24.47 | 3.08B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
144.12 | 63.49B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.99 | 43.84B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.415 | 40.97B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.14 | 22.52B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
431.11 | 19.57B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-22 | Fortgesetzt | Jefferies | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Indivior Plc Aktie (INDV) Neueste Nachrichten
Indivior to Report Third Quarter 2025 Financial Results and Host Webcast on October 30th - Eastern Progress
Using Python tools to backtest Indivior PLC strategiesChart Signals & Free Accurate Trade Setup Notifications - newser.com
How Indivior PLC stock performs in rising dollar environmentJuly 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com
Can Indivior PLC stock reach $100 price targetPortfolio Risk Report & Stepwise Entry and Exit Trade Signals - newser.com
How Indivior PLC stock trades during market volatilityJuly 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
Q3 2025 Results on Oct. 30 — Indivior to Host Live Webcast; replay available - Stock Titan
Indivior (NasdaqGS:INDV): Fresh Clinical Data Prompts a Closer Look at Current Valuation - Yahoo
Indivior Q2 2025 presentation: SUBLOCADE growth drives raised guidance By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 25.1 USD By Investing.com - Investing.com Nigeria
Indivior stock hits 52-week high at 25.1 USD - Investing.com
Using AI based signals to follow Indivior PLCPortfolio Risk Report & Real-Time Stock Entry Alerts - newser.com
Clinical Evidence Supports Rapid SUBLOCADE® Induction as a Strategy to Improve Retention in Opioid Use Disorder Treatment - StreetInsider
Clinical Evidence Supports Rapid SUBLOCADE Induction As A Strategy To Improve Retention In Opioid Use Disorder Treatment - TradingView
Indivior: SUBLOCADE Rapid Induction Raises Retention at 2nd Injection | INDV Stock News - Stock Titan
News impact scoring models applied to Indivior PLCWeekly Loss Report & Daily Chart Pattern Signal Reports - newser.com
Is Indivior PLC stock reversal real or fake2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Earnings call transcript: Indivior’s Q2 2025 revenue rises, guidance boosted - Investing.com
Earnings call transcript: Indivior’s Q2 2025 revenue rises, guidance boosted By Investing.com - Investing.com Canada
Will Indivior PLC stock deliver long term returnsJuly 2025 Outlook & Short-Term High Return Strategies - newser.com
Substance Abuse Treatment Market to Witness Remarkable Growth With Indivior PLC, Pfizer, Inc. - openPR.com
Chart based exit strategy for Indivior PLCEarnings Trend Report & Scalable Portfolio Growth Methods - newser.com
Indivior targets $1.5B peak revenue for Sublocade amid 2025 transition plans - MSN
Will Indivior PLC stock rally after Fed decisionsMarket Weekly Review & Weekly Momentum Picks - newser.com
Will Indivior PLC benefit from macro trendsJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
Strategies to average down on Indivior PLCJuly 2025 Review & Target Return Focused Picks - newser.com
Indivior PLC stock outlook for YEARTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Indivior PLC outperform the marketJuly 2025 Action & Expert Curated Trade Setups - newser.com
What indicators show strength in Indivior PLCTrade Analysis Report & Daily Volume Surge Signals - newser.com
U.S. Suboxone Market Set to See Booming Growth 2025-2032 Driven by Key Players like Indivior, Teva, and Alcami - openPR.com
Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com
What the charts say about Indivior PLC today2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Indivior Launches Action Agenda for Business Enhancement - MSN
What analysts say about Indivior PLC stockHigh Dividend Yield Stocks & Big Profit Small Budget - earlytimes.in
Automated trading signals detected on Indivior PLC2025 Short Interest & Daily Volume Surge Trade Alerts - newser.com
Full technical analysis of Indivior PLC stockJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Why Indivior PLC stock remains resilient2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Should you wait for a breakout in Indivior PLC2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Can momentum traders help lift Indivior PLCMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.39%
14.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):